Clinicians flag safety concerns for Prader-Willi drug after 7 deaths

VYKAT XR (diazoxide choline), the first FDA-approved medication specifically indicated for hyperphagia in patients ages 4 and older with Prader-Willi syndrome, is facing increased safety scrutiny following reports of seven deaths and more than 100 serious adverse events. The reported events included edema and respiratory and cardiac complications. The FDA’s Adverse Event Reporting System has […] The post Clinicians flag safety concerns for Prader-Willi drug after 7 deaths appeared fi...